Literature DB >> 16510875

Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.

Nathan P Gomes1, Glen Bjerke, Briardo Llorente, Stephanie A Szostek, Beverly M Emerson, Joaquin M Espinosa.   

Abstract

Activation of the p53 pathway mediates cellular responses to diverse forms of stress. Here we report that the p53 target gene p21(CIP1) is regulated by stress at post-initiation steps through conversion of paused RNA polymerase II (RNAP II) into an elongating form. High-resolution chromatin immunoprecipitation assays (ChIP) demonstrate that p53-dependent activation of p21(CIP1) transcription after DNA damage occurs concomitantly with changes in RNAP II phosphorylation status and recruitment of the elongation factors DSIF (DRB Sensitivity-Inducing Factor), P-TEFb (Positive Transcription Elongation Factor b), TFIIH, TFIIF, and FACT (Facilitates Chromatin Transcription) to distinct regions of the p21(CIP1) locus. Paradoxically, pharmacological inhibition of P-TEFb leads to global inhibition of mRNA synthesis but activation of the p53 pathway through p53 accumulation, expression of specific p53 target genes, and p53-dependent apoptosis. ChIP analyses of p21(CIP1) activation in the absence of functional P-TEFb reveals the existence of two distinct kinases that phosphorylate Ser5 of the RNAP II C-terminal domain (CTD). Importantly, CTD phosphorylation at Ser2 is not required for p21(CIP1) transcription, mRNA cleavage, or polyadenylation. Furthermore, recruitment of FACT requires CTD kinases, yet FACT is dispensable for p21(CIP1) expression. Thus, select genes within the p53 pathway bypass the requirement for P-TEFb and RNAP II phosphorylation to trigger a cellular response to inhibition of global mRNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510875      PMCID: PMC1410802          DOI: 10.1101/gad.1398206

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  50 in total

1.  Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain.

Authors:  E J Cho; M S Kobor; M Kim; J Greenblatt; S Buratowski
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

Review 2.  Integrating mRNA processing with transcription.

Authors:  Nick J Proudfoot; Andre Furger; Michael J Dye
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

3.  Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences.

Authors:  Y Ramanathan; S M Rajpara; S M Reza; E Lees; S Shuman; M B Mathews; T Pe'ery
Journal:  J Biol Chem       Date:  2001-01-16       Impact factor: 5.157

4.  Dynamics of enhancer-promoter communication during differentiation-induced gene activation.

Authors:  Pantelis Hatzis; Iannis Talianidis
Journal:  Mol Cell       Date:  2002-12       Impact factor: 17.970

Review 5.  Regulation of transcription elongation by phosphorylation.

Authors:  Michael S Kobor; Jack Greenblatt
Journal:  Biochim Biophys Acta       Date:  2002-09-13

Review 6.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

7.  NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation.

Authors:  Y Yamaguchi; T Takagi; T Wada; K Yano; A Furuya; S Sugimoto; J Hasegawa; H Handa
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

Review 8.  Activation of the p53 tumor suppressor protein.

Authors:  Karen H Vousden
Journal:  Biochim Biophys Acta       Date:  2002-03-14

9.  CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo.

Authors:  Eun Yong Shim; Amy K Walker; Yang Shi; T Keith Blackwell
Journal:  Genes Dev       Date:  2002-08-15       Impact factor: 11.361

10.  Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol.

Authors:  L T Lam; O K Pickeral; A C Peng; A Rosenwald; E M Hurt; J M Giltnane; L M Averett; H Zhao; R E Davis; M Sathyamoorthy; L M Wahl; E D Harris; J A Mikovits; A P Monks; M G Hollingshead; E A Sausville; L M Staudt
Journal:  Genome Biol       Date:  2001-09-13       Impact factor: 13.583

View more
  158 in total

1.  MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress.

Authors:  Lynn Biderman; Masha V Poyurovsky; Yael Assia; James L Manley; Carol Prives
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

2.  Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Authors:  Jessica Finlay-Schultz; Andrew Canastar; Margaret Short; Mohamed El Gazzar; Christina Coughlan; Sherry Leonard
Journal:  J Biol Chem       Date:  2011-10-06       Impact factor: 5.157

3.  Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

4.  Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Genes Dev       Date:  2010-05-15       Impact factor: 11.361

5.  Distinct alterations in chromatin organization of the two IGF-I promoters precede growth hormone-induced activation of IGF-I gene transcription.

Authors:  Dennis J Chia; Jennifer J Young; April R Mertens; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2010-02-16

6.  RNA polymerase II C-terminal domain phosphorylation patterns in Caenorhabditis elegans operons, polycistronic gene clusters with only one promoter.

Authors:  Alfonso Garrido-Lecca; Thomas Blumenthal
Journal:  Mol Cell Biol       Date:  2010-05-24       Impact factor: 4.272

7.  Transcriptional regulation of HIV-1 gene expression by p53.

Authors:  Ruma Mukerjee; Pier Paolo Claudio; J Robert Chang; Luis Del Valle; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

8.  Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II.

Authors:  Paul Verbruggen; Marius Ruf; Gjon Blakqori; Anna K Överby; Martin Heidemann; Dirk Eick; Friedemann Weber
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

9.  Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation.

Authors:  Joanna Y Ip; Dominic Schmidt; Qun Pan; Arun K Ramani; Andrew G Fraser; Duncan T Odom; Benjamin J Blencowe
Journal:  Genome Res       Date:  2010-12-16       Impact factor: 9.043

Review 10.  Connections between 3'-end processing and DNA damage response.

Authors:  Murat A Cevher; Frida E Kleiman
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-25       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.